Advances in the computational development of DNA methyltransferase inhibitors

José L. Medina-Franco, Thomas Caulfield

Research output: Contribution to journalReview article

60 Scopus citations

Abstract

DNA methylation is an epigenetic change that results in the addition of a methyl group at the carbon-5 position of cytosine residues. The process is mediated by DNA methyltransferases (DNMTs), a family of enzymes for which inhibition is a promising strategy for the treatment of cancer and other diseases. Here, we review the current status of the computational studies directed to rationalize, at the molecular level, the enzymatic activity of DNMT inhibitors. We also review successful virtual screenings to identify inhibitors with novel scaffolds as well as the emerging efforts to characterize the dynamic behavior of DNMTs. Thus, computational approaches form part of multidisciplinary efforts to further advance epigenetic therapies.

Original languageEnglish (US)
Pages (from-to)418-425
Number of pages8
JournalDrug Discovery Today
Volume16
Issue number9-10
DOIs
StatePublished - May 1 2011

    Fingerprint

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Cite this